Clinical Trial Update: Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis [EARLY_Phase 1]

View source ↗

Summary

Completed human factors study evaluating a Methotrexate prefilled pen (50 mg/mL) for administering methotrexate in Juvenile Idiopathic Arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Methotrexate Prefilled Pen (50 mg/mL) (Methotrexate)

Snippet

Sponsor: medac GmbH | Conditions: Juvenile Idiopathic Arthritis | EARLY_Phase 1 | Status: COMPLETED